Disease Process and Prognosis for Severe Sepsis Due to UTI/Urosepsis
Disease Process
Urosepsis is defined as life-threatening organ dysfunction resulting from a dysregulated host response to infection originating in the urinary tract, and it accounts for approximately 25% of all sepsis cases. 1, 2, 3
Pathophysiology
- The disease process begins when pathogen-associated molecular patterns are recognized by pattern recognition receptors of the host innate immune system, generating pro-inflammatory cytokines 3
- This transitions from innate to adaptive immune response until a T(H2) anti-inflammatory response leads to immunosuppression 3
- Urosepsis almost exclusively develops from complicated urinary tract infections with involvement of parenchymatous urogenital organs such as kidneys and prostate 2, 4
- The most common underlying cause is obstructed uropathy of the upper urinary tract, with ureterolithiasis being the most frequent etiology 3, 5
Clinical Presentation and Diagnosis
- Organ dysfunction is clinically indicated by an increase in Sequential Organ Failure Assessment (SOFA) score of 2 points or more 2
- The quick SOFA (qSOFA) criteria include: respiratory rate ≥22 breaths/min, altered mental status, and systolic blood pressure ≤100 mmHg 2
- Two or more qSOFA criteria should trigger immediate concern for sepsis 2
- Upon initial diagnosis, 79% of patients present with organ failure, and within 30 days an additional 5% develop organ failure, resulting in 84% total affected 6
Progression to Septic Shock
- Septic shock is defined as persistent hypotension (SBP <90 mmHg or MAP <65 mmHg) despite adequate fluid resuscitation, or lactate >4 mmol/L after fluid resuscitation 2
- In some studies, 40% of patients treated with intensive chemotherapy developed severe sepsis or septic shock 7
- All patients who died had a SOFA score of ≥2 at diagnosis 6
Prognosis
The 30-day mortality rate for urosepsis is 2.8% overall, rising to 4.6% for severe sepsis, though historical mortality rates for severe sepsis and septic shock range from 30-40%. 3, 6
Mortality Predictors
The following factors are significantly associated with worse 30-day outcomes (organ failure and death):
- Charlson Comorbidity Index score (OR 1.14, CI 1.01-1.28) 6
- Respiratory failure at baseline (OR 2.35, CI 1.32-4.21) 6
- ICU admission within past 12 months (OR 2.05, CI 1.00-4.19) 6
- Obstruction causative of urosepsis (OR 1.76, CI 1.02-3.05) 6
- Multi-drug-resistant (MDR) pathogens (OR 2.01, CI 1.15-3.53) 6
- SOFA baseline score ≥2 (OR 2.74, CI 1.49-5.07) 6
Prognostic Tools
- qSOFA score demonstrates the best predictive value with AUC of 90.3%, specificity 91.30%, and sensitivity 74.17% for predicting risk of death 8
- SOFA score shows specificity 91.33% and sensitivity 76.82% for mortality prediction 8
- Procalcitonin (PCT) demonstrates specificity 69.57% and sensitivity 77.33% for mortality prediction 8
- Patients with Charlson Comorbidity Index greater than 10 require more aggressive treatment due to increased mortality 8
Demographic Variations
- Age progression correlates with worsening outcomes: average age 56.86 years for SIRS, 60.37 years for sepsis, 69.03 years for septic shock, and 71.04 years for deceased patients (p < 0.04) 8
- Pediatric patients have lower mortality rates than adults, though fulminant purpuric sepsis warrants separate consideration 7
- In children, prognosis depends on prompt diagnosis and intervention with aggressive fluid therapy and early antibiotics 7
Critical Prognostic Factors
- Time to treatment is critical: the shorter the time to effective treatment, the higher the success rate 4
- Delaying antimicrobial therapy beyond one hour in patients with septic shock significantly increases mortality 1
- Even with optimal treatment, mortality remains approximately 10% 2
- The presence and degree of multiple organ dysfunction and development of septic shock defined by volume-refractory hypotension are key prognostic factors 7
Common Pitfalls
- SOFA and qSOFA scores adequately describe septic shock patients but fail to accurately diagnose sepsis, showing high specificity but low sensitivity, creating risk of false negative diagnosis 8
- These scores should not replace conventional triage protocols 8
- The Sepsis-3 guidelines discontinued use of SIRS criteria for sepsis classification, though SIRS remains useful as a screening tool 2
- Increased hospitalization costs are observed in deceased patients and those with septic shock 8